Melafind
Optical diagnostic device for melanoma detection. PMA P090012, from Strata Skin Sciences, Inc. (Horsham, PA). Product code OYD, class 3.
As of Nov 18, 2026, P090012 is an FDA PMA held by Strata Skin Sciences, Inc., approved on Nov 1, 2011 after 881 days, with 1 recall tied to it in FDA's recall database.
- Review time: 881 days
- Supplements: 11
- Recalls: 1
What FDA approved
FDA's approval order statementApproval for the melafind device. Melafind is intended for use on clinically atypical cutaneous pigmented lesions with one or more clinical or historical characteristics of melanoma, excluding those with a clinical diagnosis of melanoma or likely melanoma. Melafind is designed to be used when a dermatologist chooses to obtain additional information for a decision to biopsy. Melafind should not be used to confirm a clinical diagnosis of melanoma. Melafind is only for use by physicians trained in the clinical diagnosis and management of skin cancer (i.e., dermatologists) who have also successfully completed a training program in the appropriate use of melafind.the melafind result is one element of the overall clinical assessment. Melafind positive lesions (which may include malignant melanoma, melanoma in situ, high grade dysplastic nevi and atypical melanocytic…
Pivotal study
The main clinical evidence FDA relied on, as its Summary of Safety and Effectiveness describes it- Design
- Prospective, multi-center, blinded study of atypical pigmented lesions vs. dermatopathology reference standard
- Enrolled
- 1,831
- Where
- 7 sites, US
- Primary endpoint
- Sensitivity for melanoma among F3/F4 lesions at least 95% at 95% lower confidence bound (Aim 1); specificity superior to dermatologists (Aim 2)
- Result
- Met: sensitivity 98.3% (112/114; 95% LCB 95.1%); specificity 10.6% vs. 5.5% for dermatologists
Recalls
Recalls FDA ties to P090012, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record| Started | Recall | Status |
|---|---|---|
| Apr 2, 2015 | Z-1636-2015The probability and histogram data within the Melafind's device displayed user interface lacks approval (not included in the PMA supplement). | Terminated |
Supplements
11 supplements to this PMA| Aug 18, 2016 | S011Change Design/Components/Specifications/Material | Normal 180 Day Track |
| Mar 2, 2016 | S010Labeling Change - Indications/instructions/shelf life/tradename | Normal 180 Day Track |
| Jan 12, 2016 | S006Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Oct 22, 2015 | S004Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Jan 26, 2015 | S008Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Dec 19, 2014 | S005Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Nov 26, 2014 | S007Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
| Oct 22, 2014 | S003Postapproval Study Protocol - OSB | Normal 180 Day Track No User Fee |
| Jul 7, 2014 | S009Process Change - Manufacturer/Sterilizer/Packager/Supplier | 30-Day Notice |
| Oct 2, 2012 | S002Postapproval Study Protocol - OSB | Normal 180 Day Track No User Fee |
| Aug 8, 2012 | S001Postapproval Study Protocol - OSB | Normal 180 Day Track No User Fee |
Elsewhere
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
Record
- Document
- Approval order (PDF) ↗
- Type
- Original PMA, expedited
- Received
- Jun 3, 2009
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.1820
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files